The Latest Breaking News from NYSE

Analyzing Merck & Company Inc. New's Short Interest

Merck & Company Inc (new's (NYSE: MRK) short percent of float has fallen 12.5% since its last report. The company recently reported that it has 17.65 million shares sold short, which is 0.7% of all regular shares that are available for trading.

Benzinga · Mar 17, 2022

Peering Into Teladoc Health Inc's Recent Short Interest

Teladoc Health Inc's (NYSE:TDOC) short percent of float has risen 5.54% since its last report. The company recently reported that it has 23.57 million shares sold short, which is 15.42% of all regular shares that are available for trading.

Benzinga · Mar 17, 2022

PureCycle Reveals Two New Appointments To Board; Richard Brenner Resigns

PureCycle Technologies Inc (NASDAQ:PCT) appointed two new board members, effective March 15, 2022. The new independent members are Steven F. Bouck, former president of Waste Connections, Inc. (NYSE:WCN), and Allen Jacoby, chief strategy officer and senior vice president of corporate development for Milliken & Company.  PureCycle also disclosed the resignation of founding board member…

Benzinga · Mar 17, 2022

Looking At AbbVie's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 48 strange trades.

Benzinga · Mar 17, 2022

Western Sanctions To Negatively Affect General Dynamics' Jet Maintenance Unit: Reuters

General Dynamics Corp (NYSE:GD), at the J.P. Morgan Industrials conference held on March 16, 2022, stated that its jet aviation business is likely to be impacted by Western sanctions on Moscow over its invasion of Ukraine, reported Reuters. The report added that the company's Jet Aviation unit is likely to be hit…

Benzinga · Mar 17, 2022

35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill

Thirty-five generic drugmakers will produce low-cost versions of Pfizer Inc's (NYSE:PFE) COVID-19 pill, Paxlovid, to expand supplies of the highly effective drug in lower-income regions. Pfizer struck a deal last year with the group to allow generic drugmakers to make the pills for 95 low- and middle-income countries, covering up to approximately 53% of the…

Benzinga · Mar 17, 2022

Barclays Cuts Equifax's Price Target By 9%

Equifax Inc's (NYSE:EFX) price target has been lowered to $300 (an upside of 26%) from $330 by Barclays analyst Manav Patnaik. The analyst maintained his Overweight rating on EFX's shares. Patnaik's price target reduction mirrors market de-rating and the recession risk. Meanwhile, the analyst appreciates the diversity of the company's solution sets and tech-powered innovation…

Benzinga · Mar 17, 2022

Expert Ratings For Royal Caribbean Gr

Analysts have provided the following ratings for Royal Caribbean Gr (NYSE:RCL) within the last quarter:

Benzinga · Mar 17, 2022

Looking Into Nike Inc's Recent Short Interest

Nike Inc's (NYSE:NKE) short percent of float has risen 12.12% since its last report. The company recently reported that it has 9.14 million shares sold short, which is 0.74% of all regular shares that are available for trading.

Benzinga · Mar 17, 2022

Expert Ratings For Genius Sports

Over the past 3 months, 4 analysts have published their opinion on Genius Sports (NYSE:GENI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Mar 17, 2022